Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	HLA-F RAET1G ULBP2 MICA RAET1L	6.05e-08	17	129	5	GO:0046703
GeneOntologyMolecularFunction	L-lactate dehydrogenase activity	LDHAL6A LDHB LDHC	2.61e-06	5	129	3	GO:0004459
GeneOntologyMolecularFunction	lactate dehydrogenase activity	LDHAL6A LDHB LDHC	5.19e-06	6	129	3	GO:0004457
GeneOntologyMolecularFunction	peptide antigen binding	HLA-DQA1 HLA-DQA2 HLA-F MICA	2.81e-04	49	129	4	GO:0042605
GeneOntologyMolecularFunction	SH3 domain binding	MICAL1 CTTNBP2 BCAR1 ZNF106 ARHGAP31 FUT8	3.35e-04	143	129	6	GO:0017124
GeneOntologyMolecularFunction	cytoskeletal regulatory protein binding	CTTNBP2 CDC42EP3	4.09e-04	5	129	2	GO:0005519
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	8.16e-09	25	128	6	GO:0002475
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	HLA-F RAET1G ULBP2 MICA RAET1L	3.52e-08	16	128	5	GO:0002486
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous antigen	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	4.03e-08	32	128	6	GO:0019883
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	HLA-F RAET1G ULBP2 MICA RAET1L	4.96e-08	17	128	5	GO:0002484
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib	HLA-F RAET1G ULBP2 MICA RAET1L	4.96e-08	17	128	5	GO:0002476
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class Ib	HLA-F RAET1G ULBP2 MICA RAET1L	6.83e-08	18	128	5	GO:0002428
GeneOntologyBiologicalProcess	positive regulation of T cell mediated cytotoxicity	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	2.22e-07	42	128	6	GO:0001916
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I	HLA-F RAET1G ULBP2 MICA RAET1L	2.62e-07	23	128	5	GO:0019885
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen	HLA-F RAET1G ULBP2 MICA RAET1L	4.09e-07	25	128	5	GO:0002483
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen	HLA-DQA1 HLA-DQA2 HLA-F RAET1G ULBP2 MICA RAET1L	4.60e-07	76	128	7	GO:0048002
GeneOntologyBiologicalProcess	regulation of T cell mediated cytotoxicity	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	9.18e-07	53	128	6	GO:0001914
GeneOntologyBiologicalProcess	antigen processing and presentation	HLA-DQA1 HLA-DQA2 HLA-F RAET1G CD1E ULBP2 MICA RAET1L	2.52e-06	139	128	8	GO:0019882
GeneOntologyBiologicalProcess	T cell mediated cytotoxicity	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	4.81e-06	70	128	6	GO:0001913
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class I	HLA-F RAET1G ULBP2 MICA RAET1L	5.33e-06	41	128	5	GO:0002474
GeneOntologyBiologicalProcess	regulation of T cell mediated immunity	TRPM4 HLA-F RAET1G CD1E ULBP2 MICA RAET1L	5.98e-06	111	128	7	GO:0002709
GeneOntologyBiologicalProcess	positive regulation of T cell mediated immunity	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	6.66e-06	74	128	6	GO:0002711
GeneOntologyBiologicalProcess	positive regulation of leukocyte mediated cytotoxicity	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	9.74e-06	79	128	6	GO:0001912
GeneOntologyBiologicalProcess	endoderm development	COL12A1 TNRC6C CFC1 TNRC6A ANKRD17 CFC1B	1.81e-05	88	128	6	GO:0007492
GeneOntologyBiologicalProcess	positive regulation of cell killing	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	1.81e-05	88	128	6	GO:0031343
GeneOntologyBiologicalProcess	susceptibility to natural killer cell mediated cytotoxicity	RAET1G ULBP2 RAET1L	1.91e-05	9	128	3	GO:0042271
GeneOntologyBiologicalProcess	regulation of nitric oxide biosynthetic process	HLA-F RAET1G PTGIS NFATC3 ULBP2 RAET1L	3.16e-05	97	128	6	GO:0045428
GeneOntologyBiologicalProcess	regulation of cell killing	HLA-F RAET1G CFHR4 CD1E ULBP2 MICA RAET1L	3.73e-05	147	128	7	GO:0031341
GeneOntologyBiologicalProcess	regulation of nitric oxide metabolic process	HLA-F RAET1G PTGIS NFATC3 ULBP2 RAET1L	3.76e-05	100	128	6	GO:0080164
GeneOntologyBiologicalProcess	regulation of natural killer cell activation	RAET1G PRDM1 ULBP2 MICA RAET1L	3.83e-05	61	128	5	GO:0032814
GeneOntologyBiologicalProcess	positive regulation of nitric oxide biosynthetic process	HLA-F RAET1G NFATC3 ULBP2 RAET1L	5.22e-05	65	128	5	GO:0045429
GeneOntologyBiologicalProcess	positive regulation of nitric oxide metabolic process	HLA-F RAET1G NFATC3 ULBP2 RAET1L	6.04e-05	67	128	5	GO:1904407
GeneOntologyBiologicalProcess	nitric oxide biosynthetic process	HLA-F RAET1G PTGIS NFATC3 ULBP2 RAET1L	7.10e-05	112	128	6	GO:0006809
GeneOntologyBiologicalProcess	T cell mediated immunity	TRPM4 HLA-F RAET1G CD1E ULBP2 MICA RAET1L	7.18e-05	163	128	7	GO:0002456
GeneOntologyBiologicalProcess	positive regulation of natural killer cell mediated cytotoxicity	HLA-F RAET1G ULBP2 RAET1L	1.09e-04	40	128	4	GO:0045954
GeneOntologyBiologicalProcess	nitric oxide metabolic process	HLA-F RAET1G PTGIS NFATC3 ULBP2 RAET1L	1.09e-04	121	128	6	GO:0046209
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated cytotoxicity	HLA-F RAET1G ULBP2 MICA RAET1L	1.10e-04	76	128	5	GO:0042269
GeneOntologyBiologicalProcess	reactive nitrogen species metabolic process	HLA-F RAET1G PTGIS NFATC3 ULBP2 RAET1L	1.19e-04	123	128	6	GO:2001057
GeneOntologyBiologicalProcess	regulation of leukocyte mediated cytotoxicity	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	1.25e-04	124	128	6	GO:0001910
GeneOntologyBiologicalProcess	natural killer cell activation	HLA-F RAET1G PRDM1 ULBP2 MICA RAET1L	1.25e-04	124	128	6	GO:0030101
GeneOntologyBiologicalProcess	regulation of natural killer cell mediated immunity	HLA-F RAET1G ULBP2 MICA RAET1L	1.41e-04	80	128	5	GO:0002715
GeneOntologyBiologicalProcess	positive regulation of natural killer cell mediated immunity	HLA-F RAET1G ULBP2 RAET1L	1.58e-04	44	128	4	GO:0002717
GeneOntologyBiologicalProcess	lactate biosynthetic process from pyruvate	LDHB LDHC	2.27e-04	4	128	2	GO:0019244
GeneOntologyBiologicalProcess	left lung morphogenesis	CFC1 CFC1B	2.27e-04	4	128	2	GO:0060460
GeneOntologyBiologicalProcess	cellular response to exogenous dsRNA	RAET1G ULBP2 RAET1L	3.30e-04	22	128	3	GO:0071360
GeneOntologyBiologicalProcess	positive regulation of lymphocyte mediated immunity	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	3.50e-04	150	128	6	GO:0002708
GeneOntologyBiologicalProcess	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	3.50e-04	150	128	6	GO:0002824
GeneOntologyBiologicalProcess	left lung development	CFC1 CFC1B	3.77e-04	5	128	2	GO:0060459
GeneOntologyBiologicalProcess	immune response to tumor cell	RAET1G ULBP2 MICA RAET1L	4.05e-04	56	128	4	GO:0002418
GeneOntologyBiologicalProcess	neuron migration	KIF26A DISC1 SDCCAG8 APBB1 LRIG2 PTPRZ1 PLXNA1	4.29e-04	218	128	7	GO:0001764
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous antigen	HLA-DQA1 HLA-DQA2 HLA-F CD1E	4.63e-04	58	128	4	GO:0019884
GeneOntologyBiologicalProcess	positive regulation of adaptive immune response	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	4.78e-04	159	128	6	GO:0002821
GeneOntologyBiologicalProcess	lactate metabolic process	LDHAL6A LDHB LDHC	4.86e-04	25	128	3	GO:0006089
GeneOntologyBiologicalProcess	natural killer cell mediated cytotoxicity	HLA-F RAET1G ULBP2 MICA RAET1L	5.00e-04	105	128	5	GO:0042267
GeneOntologyBiologicalProcess	nodal signaling pathway	ZIC2 CFC1 CFC1B	5.47e-04	26	128	3	GO:0038092
GeneOntologyBiologicalProcess	natural killer cell mediated immunity	HLA-F RAET1G ULBP2 MICA RAET1L	5.94e-04	109	128	5	GO:0002228
GeneOntologyBiologicalProcess	regulation of lymphocyte mediated immunity	TRPM4 HLA-F RAET1G CD1E ULBP2 MICA RAET1L	6.21e-04	232	128	7	GO:0002706
GeneOntologyBiologicalProcess	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	TRPM4 HLA-F RAET1G CD1E ULBP2 MICA RAET1L	6.70e-04	235	128	7	GO:0002822
GeneOntologyBiologicalProcess	cellular response to dsRNA	RAET1G ULBP2 RAET1L	6.83e-04	28	128	3	GO:0071359
GeneOntologyBiologicalProcess	positive regulation of response to tumor cell	RAET1G ULBP2 RAET1L	6.83e-04	28	128	3	GO:0002836
GeneOntologyBiologicalProcess	positive regulation of immune response to tumor cell	RAET1G ULBP2 RAET1L	6.83e-04	28	128	3	GO:0002839
GeneOntologyBiologicalProcess	adaptive immune response	TRPM4 HLA-DQA1 HLA-DQA2 HLA-F RAET1G XRCC4 CFHR4 PRDM1 CD1E FGA ULBP2 MICA RAET1L FCRL4	7.13e-04	838	128	14	GO:0002250
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	KIF26A CDHR2 DISC1 SDCCAG8 HLA-F APBB1 CDC42EP3 LRIG2 PTPRZ1 GORASP1 SYNE2 RPL4 ALK PLXNA1	7.82e-04	846	128	14	GO:0120035
GeneOntologyBiologicalProcess	lactate biosynthetic process	LDHB LDHC	7.86e-04	7	128	2	GO:0019249
GeneOntologyBiologicalProcess	positive regulation of leukocyte mediated immunity	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	7.90e-04	175	128	6	GO:0002705
GeneOntologyBiologicalProcess	regulation of cell projection organization	KIF26A CDHR2 DISC1 SDCCAG8 HLA-F APBB1 CDC42EP3 LRIG2 PTPRZ1 GORASP1 SYNE2 RPL4 ALK PLXNA1	9.48e-04	863	128	14	GO:0031344
GeneOntologyBiologicalProcess	response to tumor cell	RAET1G ULBP2 MICA RAET1L	9.97e-04	71	128	4	GO:0002347
GeneOntologyBiologicalProcess	regulation of adaptive immune response	TRPM4 HLA-F RAET1G CD1E ULBP2 MICA RAET1L	1.01e-03	252	128	7	GO:0002819
GeneOntologyBiologicalProcess	regulation of immune effector process	TRPM4 MASP1 HLA-F RAET1G CFHR4 CD1E ANKRD17 ULBP2 MICA RAET1L	1.08e-03	497	128	10	GO:0002697
GeneOntologyBiologicalProcess	nuclear-transcribed mRNA poly(A) tail shortening	TNRC6C TNRC6A TNKS1BP1	1.11e-03	33	128	3	GO:0000289
GeneOntologyBiologicalProcess	axon ensheathment in central nervous system	SOX10 MAL CNTNAP2	1.11e-03	33	128	3	GO:0032291
GeneOntologyBiologicalProcess	central nervous system myelination	SOX10 MAL CNTNAP2	1.11e-03	33	128	3	GO:0022010
GeneOntologyBiologicalProcess	leukocyte mediated cytotoxicity	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	1.11e-03	187	128	6	GO:0001909
GeneOntologyBiologicalProcess	positive regulation of natural killer cell activation	RAET1G ULBP2 RAET1L	1.32e-03	35	128	3	GO:0032816
GeneOntologyCellularComponent	extracellular matrix	FLG COL12A1 IMPG1 RBP3 ITLN2 HRNR LRIG2 SNED1 CELA3B CELA3A PTPRZ1 FGA LOXL4 CTSZ COL1A1	1.20e-05	656	128	15	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	FLG COL12A1 IMPG1 RBP3 ITLN2 HRNR LRIG2 SNED1 CELA3B CELA3A PTPRZ1 FGA LOXL4 CTSZ COL1A1	1.24e-05	658	128	15	GO:0030312
GeneOntologyCellularComponent	collagen-containing extracellular matrix	FLG COL12A1 IMPG1 RBP3 ITLN2 HRNR CELA3B CELA3A PTPRZ1 FGA LOXL4 CTSZ COL1A1	2.29e-05	530	128	13	GO:0062023
GeneOntologyCellularComponent	external side of plasma membrane	HLA-DQA1 HLA-DQA2 HLA-F RAET1G CFHR4 CD1E FGA ULBP2 MICA RAET1L FCRL4 HYAL2	8.44e-05	519	128	12	GO:0009897
GeneOntologyCellularComponent	side of membrane	HLA-DQA1 HLA-DQA2 HLA-F RAET1G ITLN2 CFHR4 CD1E CFC1 FGA ULBP2 MICA CFC1B RAET1L FCRL4 HYAL2	3.03e-04	875	128	15	GO:0098552
GeneOntologyCellularComponent	keratohyalin granule	FLG HRNR	3.68e-04	5	128	2	GO:0036457
GeneOntologyCellularComponent	cell surface	HLA-DQA1 HLA-DQA2 HLA-F RAET1G RTN2 CFHR4 CD1E CFC1 CNTNAP2 FGA ULBP2 MICA CFC1B RAET1L FCRL4 CTSZ HYAL2	4.43e-04	1111	128	17	GO:0009986
GeneOntologyCellularComponent	MHC protein complex	HLA-DQA1 HLA-DQA2 HLA-F	5.26e-04	26	128	3	GO:0042611
GeneOntologyCellularComponent	interphotoreceptor matrix	IMPG1 RBP3	5.49e-04	6	128	2	GO:0033165
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-DQA1 HLA-DQA2 HLA-F	1.27e-03	35	128	3	GO:0098553
Domain	MHC_I/II-like_Ag-recog	HLA-DQA1 HLA-DQA2 HLA-F RAET1G CD1E ULBP2 MICA RAET1L	1.41e-10	38	126	8	IPR011162
Domain	-	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	1.02e-08	24	126	6	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-F RAET1G CD1E ULBP2 MICA RAET1L	1.02e-08	24	126	6	IPR011161
Domain	MHC_I	HLA-F RAET1G ULBP2 MICA RAET1L	2.41e-07	21	126	5	PF00129
Domain	MHC_I_a_a1/a2	HLA-F RAET1G ULBP2 MICA RAET1L	2.41e-07	21	126	5	IPR001039
Domain	FIBRINOGEN_C_1	CNTNAP3B CNTNAP3 ITLN2 CNTNAP2 FGA	2.25e-06	32	126	5	PS00514
Domain	Fibrinogen_a/b/g_C_dom	CNTNAP3B CNTNAP3 ITLN2 CNTNAP2 FGA	2.25e-06	32	126	5	IPR002181
Domain	FIBRINOGEN_C_2	CNTNAP3B CNTNAP3 ITLN2 CNTNAP2 FGA	2.25e-06	32	126	5	PS51406
Domain	L_LDH	LDHAL6A LDHB LDHC	2.97e-06	5	126	3	PS00064
Domain	L-lactate_DH	LDHAL6A LDHB LDHC	2.97e-06	5	126	3	IPR011304
Domain	L-lactate_DH_AS	LDHAL6A LDHB LDHC	2.97e-06	5	126	3	IPR018177
Domain	IG_MHC	HLA-DQA1 HLA-DQA2 HLA-F RAET1G ULBP2 RAET1L	3.11e-06	60	126	6	PS00290
Domain	FA58C	CNTNAP3B CPXM2 CNTNAP3 CNTNAP2	1.08e-05	21	126	4	SM00231
Domain	FA58C_3	CNTNAP3B CPXM2 CNTNAP3 CNTNAP2	1.08e-05	21	126	4	PS50022
Domain	FA58C_1	CNTNAP3B CPXM2 CNTNAP3 CNTNAP2	1.08e-05	21	126	4	PS01285
Domain	FA58C_2	CNTNAP3B CPXM2 CNTNAP3 CNTNAP2	1.08e-05	21	126	4	PS01286
Domain	Lactate/malate_DH_N	LDHAL6A LDHB LDHC	1.64e-05	8	126	3	IPR001236
Domain	L-lactate/malate_DH	LDHAL6A LDHB LDHC	1.64e-05	8	126	3	IPR001557
Domain	Ldh_1_N	LDHAL6A LDHB LDHC	1.64e-05	8	126	3	PF00056
Domain	F5_F8_type_C	CNTNAP3B CPXM2 CNTNAP3 CNTNAP2	1.89e-05	24	126	4	PF00754
Domain	FA58C	CNTNAP3B CPXM2 CNTNAP3 CNTNAP2	1.89e-05	24	126	4	IPR000421
Domain	-	LDHAL6A LDHB LDHC	2.44e-05	9	126	3	3.90.110.10
Domain	Lactate/malate_DH_C	LDHAL6A LDHB LDHC	2.44e-05	9	126	3	IPR022383
Domain	Ldh_1_C	LDHAL6A LDHB LDHC	2.44e-05	9	126	3	PF02866
Domain	Lactate_DH/Glyco_Ohase_4_C	LDHAL6A LDHB LDHC	2.44e-05	9	126	3	IPR015955
Domain	C1-set	HLA-DQA1 HLA-DQA2 HLA-F CD1E MICA	3.13e-05	54	126	5	PF07654
Domain	IGc1	HLA-DQA1 HLA-DQA2 HLA-F CD1E MICA	3.74e-05	56	126	5	SM00407
Domain	Ig/MHC_CS	HLA-DQA1 HLA-DQA2 HLA-F RAET1G ULBP2	4.44e-05	58	126	5	IPR003006
Domain	Ig_C1-set	HLA-DQA1 HLA-DQA2 HLA-F CD1E MICA	4.44e-05	58	126	5	IPR003597
Domain	M_domain	TNRC6C TNRC6A	4.52e-05	2	126	2	PF12938
Domain	GW182_M_dom	TNRC6C TNRC6A	4.52e-05	2	126	2	IPR026805
Domain	EGF-like_dom	CNTNAP3B MASP1 IMPG1 CNTNAP3 SNED1 CFC1 CNTNAP2 CFC1B HYAL2	4.89e-05	249	126	9	IPR000742
Domain	ConA-like_dom	CNTNAP3B COL12A1 TRIM35 CNTNAP3 MAMDC4 CNTNAP2 ALK ADGRD1	1.21e-04	219	126	8	IPR013320
Domain	Ago_hook	TNRC6C TNRC6A	1.35e-04	3	126	2	PF10427
Domain	CFC	CFC1 CFC1B	1.35e-04	3	126	2	PF09443
Domain	Cryptic/Cripto_CFC-dom	CFC1 CFC1B	1.35e-04	3	126	2	IPR019011
Domain	TNRC6_PABC-bd	TNRC6C TNRC6A	1.35e-04	3	126	2	IPR032226
Domain	Argonaute_hook_dom	TNRC6C TNRC6A	1.35e-04	3	126	2	IPR019486
Domain	TNRC6-PABC_bdg	TNRC6C TNRC6A	1.35e-04	3	126	2	PF16608
Domain	EGF_3	CNTNAP3B MASP1 CNTNAP3 SNED1 CFC1 CNTNAP2 CFC1B HYAL2	1.96e-04	235	126	8	PS50026
Domain	EGF_1	CNTNAP3B MASP1 CNTNAP3 SNED1 CFC1 CNTNAP2 CFC1B HYAL2	3.40e-04	255	126	8	PS00022
Domain	-	SEH1L DYNC2I1 ARHGEF17 BIRC6 DNAI1 ZNF106 UTP4 WDR1 PLXNA1	4.33e-04	333	126	9	2.130.10.10
Domain	EGF_2	CNTNAP3B MASP1 CNTNAP3 SNED1 CFC1 CNTNAP2 CFC1B HYAL2	4.39e-04	265	126	8	PS01186
Domain	C1-set_C	HLA-DQA1 HLA-DQA2	4.46e-04	5	126	2	PF16196
Domain	MHC_II_alpha	HLA-DQA1 HLA-DQA2	4.46e-04	5	126	2	SM00920
Domain	C1-set_C	HLA-DQA1 HLA-DQA2	4.46e-04	5	126	2	IPR032431
Domain	WD40/YVTN_repeat-like_dom	SEH1L DYNC2I1 ARHGEF17 BIRC6 DNAI1 ZNF106 UTP4 WDR1 PLXNA1	4.52e-04	335	126	9	IPR015943
Domain	-	SDK2 COL12A1 HLA-DQA1 HLA-DQA2 HLA-F LRIG2 SNED1 CD1E NFATC3 PTPRZ1 MICA FCRL4 PLXNA1	5.45e-04	663	126	13	2.60.40.10
Domain	Laminin_G	CNTNAP3B COL12A1 CNTNAP3 CNTNAP2	6.32e-04	58	126	4	IPR001791
Domain	MHC_II_alpha	HLA-DQA1 HLA-DQA2	6.65e-04	6	126	2	PF00993
Domain	MHC_II_a_N	HLA-DQA1 HLA-DQA2	9.27e-04	7	126	2	IPR001003
Domain	FBG	CNTNAP3 ITLN2 FGA	9.64e-04	29	126	3	SM00186
Domain	Ig-like_fold	SDK2 COL12A1 HLA-DQA1 HLA-DQA2 HLA-F LRIG2 SNED1 CD1E NFATC3 PTPRZ1 MICA FCRL4 PLXNA1	9.73e-04	706	126	13	IPR013783
Domain	-	CNTNAP3 ITLN2 FGA	1.07e-03	30	126	3	3.90.215.10
Domain	Fibrinogen_a/b/g_C_1	CNTNAP3 ITLN2 FGA	1.07e-03	30	126	3	IPR014716
Domain	EGF	CNTNAP3B CNTNAP3 SNED1 CFC1 CNTNAP2 CFC1B HYAL2	1.09e-03	235	126	7	SM00181
Domain	Cyt_P450_E_grp-IV	CYP26B1 PTGIS	1.96e-03	10	126	2	IPR002403
Domain	EGF-like_CS	MASP1 CNTNAP3 SNED1 CFC1 CNTNAP2 CFC1B HYAL2	1.98e-03	261	126	7	IPR013032
Domain	LAM_G_DOMAIN	CNTNAP3B CNTNAP3 CNTNAP2	2.13e-03	38	126	3	PS50025
Domain	Laminin_G_2	CNTNAP3B CNTNAP3 CNTNAP2	2.47e-03	40	126	3	PF02210
Domain	LamG	CNTNAP3B CNTNAP3 CNTNAP2	3.24e-03	44	126	3	SM00282
Domain	-	MAMDC4 RXFP2 ALK	3.68e-03	46	126	3	4.10.400.10
Domain	Galactose-bd-like	CNTNAP3B CPXM2 CNTNAP3 CNTNAP2	3.77e-03	94	126	4	IPR008979
Domain	MHC_II_a/b_N	HLA-DQA1 HLA-DQA2	3.90e-03	14	126	2	IPR014745
Domain	-	HLA-DQA1 HLA-DQA2	3.90e-03	14	126	2	3.10.320.10
Domain	-	COL12A1 CNTNAP3 CNTNAP2 ADGRD1	3.92e-03	95	126	4	2.60.120.200
Domain	WD40_repeat_dom	SEH1L DYNC2I1 ARHGEF17 DNAI1 ZNF106 UTP4 WDR1	4.05e-03	297	126	7	IPR017986
Domain	LDLRA_1	MAMDC4 RXFP2 ALK	4.16e-03	48	126	3	PS01209
Domain	LDrepeatLR_classA_rpt	MAMDC4 RXFP2 ALK	4.41e-03	49	126	3	IPR002172
Domain	LDLa	MAMDC4 RXFP2 ALK	4.41e-03	49	126	3	SM00192
Domain	LDLRA_2	MAMDC4 RXFP2 ALK	4.41e-03	49	126	3	PS50068
Domain	N2O_reductase_N	SEH1L WDR1	4.48e-03	15	126	2	IPR011045
Domain	-	ARHGAP10 SPTBN2 APBB1 ARHGEF17 RGS3 CADPS OSBPL10 TECPR1	5.06e-03	391	126	8	2.30.29.30
Domain	MAM_1	MAMDC4 ALK	5.09e-03	16	126	2	PS00740
Domain	CCP	MASP1 CFHR4 SNED1	5.79e-03	54	126	3	SM00032
Domain	NAD(P)-bd_dom	LDHAL6A DDO LDHB LDHC HSD11B2	6.39e-03	173	126	5	IPR016040
Domain	SUSHI	MASP1 CFHR4 SNED1	6.41e-03	56	126	3	PS50923
Domain	MAM	MAMDC4 ALK	6.44e-03	18	126	2	PF00629
Domain	MAM_dom	MAMDC4 ALK	6.44e-03	18	126	2	IPR000998
Domain	MAM_2	MAMDC4 ALK	6.44e-03	18	126	2	PS50060
Domain	Sushi_SCR_CCP_dom	MASP1 CFHR4 SNED1	6.73e-03	57	126	3	IPR000436
Pubmed	Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.	RAET1G ULBP2 MICA RAET1L	2.69e-09	6	129	4	10894171
Pubmed	NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.	RAET1G ULBP2 MICA RAET1L	6.27e-09	7	129	4	25583577
Pubmed	Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.	RAET1G ULBP2 RAET1L	4.99e-08	3	129	3	25212604
Pubmed	Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles.	RAET1G ULBP2 MICA RAET1L	5.84e-08	11	129	4	26656785
Pubmed	Immunoregulatory effects of HIV-1 Nef protein.	HLA-DQA1 HLA-DQA2 HLA-F ULBP2 MICA	1.21e-07	32	129	5	19449444
Pubmed	Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms.	RAET1G ULBP2 RAET1L	1.99e-07	4	129	3	20166740
Pubmed	Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules.	RAET1G ULBP2 RAET1L	1.99e-07	4	129	3	8882725
Pubmed	Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.	RAET1G ULBP2 RAET1L	1.99e-07	4	129	3	12421908
Pubmed	NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.	RAET1G ULBP2 RAET1L	1.99e-07	4	129	3	12756263
Pubmed	Murine NKG2D ligands: "double, double toil and trouble".	RAET1G ULBP2 RAET1L	1.99e-07	4	129	3	19081632
Pubmed	MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.	RAET1G ULBP2 RAET1L	4.96e-07	5	129	3	24572784
Pubmed	Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain.	RAET1G ULBP2 RAET1L	4.96e-07	5	129	3	8982867
Pubmed	Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D.	RAET1G ULBP2 RAET1L	9.89e-07	6	129	3	11825567
Pubmed	Ligands for murine NKG2D display heterogeneous binding behavior.	RAET1G ULBP2 RAET1L	9.89e-07	6	129	3	11857333
Pubmed	Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations.	RAET1G ULBP2 RAET1L	9.89e-07	6	129	3	20219610
Pubmed	The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation.	RAET1G ULBP2 RAET1L	9.89e-07	6	129	3	20976056
Pubmed	Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais.	RAET1G ULBP2 RAET1L	9.89e-07	6	129	3	19688209
Pubmed	The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60.	RAET1G ULBP2 RAET1L	1.73e-06	7	129	3	16831899
Pubmed	Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase.	RAET1G ULBP2 RAET1L	1.73e-06	7	129	3	20870941
Pubmed	Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.	RAET1G ULBP2 RAET1L	1.73e-06	7	129	3	26151313
Pubmed	NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.	RAET1G ULBP2 RAET1L	1.73e-06	7	129	3	30787931
Pubmed	Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.	RAET1G ULBP2 RAET1L	1.73e-06	7	129	3	12370332
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	TLK2 KIF26A ANKHD1 CDC42EP3 PTGIS RGS3 DAP3 TECPR1	2.73e-06	233	129	8	37704626
Pubmed	A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.	RAET1G ULBP2 RAET1L	2.75e-06	8	129	3	12645935
Pubmed	Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.	FLG HRNR FGA CTSZ COL1A1	3.55e-06	62	129	5	28344315
Pubmed	Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor.	RAET1G ULBP2 RAET1L	4.12e-06	9	129	3	14764662
Pubmed	Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells.	RAET1G ULBP2 RAET1L	4.12e-06	9	129	3	23136011
Pubmed	A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3.	RAET1G ULBP2 RAET1L	5.87e-06	10	129	3	11827464
Pubmed	Patterned variation in murine MHC promoters.	HLA-DQA1 HLA-DQA2 HLA-F	1.07e-05	12	129	3	12134058
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	TNRC6C ANKHD1 TNRC6A ANKRD17 TNKS1BP1	1.25e-05	80	129	5	35803934
Pubmed	A molecular basis for the Ia.2 and Ia.19 antigenic determinants.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	2581258
Pubmed	Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	16322110
Pubmed	Characterization of defective I-A surface expression in a mixed isotype expressing murine B cell lymphoma: continued expression of E alpha d A beta d despite competition from restored A alpha d A beta d pairs.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	1329933
Pubmed	Genetic Analysis of Human Chymotrypsin-Like Elastases 3A and 3B (CELA3A and CELA3B) to Assess the Role of Complex Formation between Proelastases and Procarboxypeptidases in Chronic Pancreatitis.	CELA3B CELA3A	1.37e-05	2	129	2	27999401
Pubmed	The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.	CFC1 CFC1B	1.37e-05	2	129	2	11174844
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	1.37e-05	2	129	2	26807827
Pubmed	Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	17142726
Pubmed	Increasing the survival of dendritic cells in vivo does not replace the requirement for CD4+ T cell help during primary CD8+ T cell responses.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	17947646
Pubmed	Molecular cloning of complementary DNA encoding one of the human pancreatic protease E isozymes.	CELA3B CELA3A	1.37e-05	2	129	2	2460440
Pubmed	Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.	HSD11B2 COL1A1	1.37e-05	2	129	2	20541046
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	1.37e-05	2	129	2	31150793
Pubmed	PCR-RFLP genotyping of murine MHC haplotypes.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	8879564
Pubmed	HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	11712854
Pubmed	Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep.	FLG HRNR	1.37e-05	2	129	2	27678121
Pubmed	Testis-specific lactate dehydrogenase (LDH-C4; Ldh3) in murine oocytes and preimplantation embryos.	LDHB LDHC	1.37e-05	2	129	2	16582413
Pubmed	Structure and expression of HLA-DQ alpha and -DX alpha genes: interallelic alternate splicing of the HLA-DQ alpha gene and functional splicing of the HLA-DQ alpha gene using a retroviral vector.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	3610256
Pubmed	Development of a major histocompatibility complex class II conditional knockout mouse to study cell-specific and time-dependent adaptive immune responses in peripheral nerves.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	38922958
Pubmed	The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	8543793
Pubmed	Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	9687536
Pubmed	Expression of type I and XII collagen during development of the periodontal ligament in the mouse.	COL12A1 COL1A1	1.37e-05	2	129	2	9796779
Pubmed	Targeted disruption of the MHC class II Aa gene in C57BL/6 mice.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	8398989
Pubmed	Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	10384102
Pubmed	Regions of allelic hypervariability in the murine A alpha immune response gene.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	6309407
Pubmed	Identification of differentially expressed genes in mouse development using differential display and in situ hybridization.	CFC1 CFC1B	1.37e-05	2	129	2	11327798
Pubmed	Intermediate steps in positive selection: differentiation of CD4+8int TCRint thymocytes into CD4-8+TCRhi thymocytes.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	7722444
Pubmed	Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	25252912
Pubmed	Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation and early cardiogenesis.	CFC1 CFC1B	1.37e-05	2	129	2	11024280
Pubmed	A comparative approach linking molecular dynamics of altered peptide ligands and MHC with in vivo immune responses.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	20657836
Pubmed	Ancient roots for polymorphism at the HLA-DQ alpha locus in primates.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	2513578
Pubmed	CD8+ T cells are capable of rejecting pancreatic islet xenografts.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	11014643
Pubmed	Identification of a novel class of elastase isozyme, human pancreatic elastase III, by cDNA and genomic gene cloning.	CELA3B CELA3A	1.37e-05	2	129	2	2826474
Pubmed	Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects.	CFC1 CFC1B	1.37e-05	2	129	2	11062482
Pubmed	Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	9334361
Pubmed	CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.	HLA-DQA1 HLA-DQA2	1.37e-05	2	129	2	12938235
Pubmed	Extensive polymorphism surrounding the murine Ia A beta chain gene.	HLA-DQA1 HLA-DQA2 HLA-F	1.39e-05	13	129	3	6311906
Pubmed	Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain.	HLA-DQA1 HLA-DQA2 HLA-F	1.39e-05	13	129	3	9973410
Pubmed	The I region of the C57BL/10 mouse: characterization and physical linkage to H-2K of an SB beta-like class II pseudogene, psi A beta 3.	HLA-DQA1 HLA-DQA2 HLA-F	1.76e-05	14	129	3	3860873
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	APBB1 GIGYF1 BCAR1 KLC4 ARHGEF17 KSR1 ZNF106 NFATC3 SYNE2 OSBPL10 ANKRD17 TNKS1BP1 CSPP1	2.01e-05	861	129	13	36931259
Pubmed	New semidominant mutations that affect mouse development.	SOX10 COL12A1 ZIC2	2.69e-05	16	129	3	15384171
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SDK2 KIF26A TRIM35 ANKHD1 NUP155 ARHGAP31 CNTNAP2 TNRC6A ANKRD17 TNKS1BP1	2.98e-05	529	129	10	14621295
Pubmed	Cell adhesion molecule contactin-associated protein 3 is expressed in the mouse basal ganglia during early postnatal stages.	CNTNAP3B CNTNAP3 CNTNAP2	3.26e-05	17	129	3	26389685
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	COL12A1 CPXM2 CPQ CTSZ COL1A1	3.87e-05	101	129	5	20551380
Pubmed	Tracts of high or low sequence divergence in the mouse major histocompatibility complex.	HLA-DQA1 HLA-DQA2 HLA-F	3.91e-05	18	129	3	6098460
Pubmed	MICA-A5.1 allele is associated with atypical forms of celiac disease in HLA-DQ2-negative patients.	HLA-DQA1 MICA	4.09e-05	3	129	2	11862400
Pubmed	MHC class II-independent CD25+ CD4+ CD8alpha beta+ alpha beta T cells attenuate CD4+ T cell-induced transfer colitis.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	14991600
Pubmed	MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ.	HLA-DQA1 MICA	4.09e-05	3	129	2	16698430
Pubmed	Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.	HLA-DQA1 MICA	4.09e-05	3	129	2	12941547
Pubmed	T cell-dependence of Lassa fever pathogenesis.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	20360949
Pubmed	Activated mouse T-cells synthesize MHC class II, process, and present morbillivirus nucleocapsid protein to primed T-cells.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	16083868
Pubmed	A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	38554988
Pubmed	Dissecting MHC class II export, B cell maturation, and DM stability defects in invariant chain mutant mice.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	15322189
Pubmed	The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia.	ULBP2 MICA	4.09e-05	3	129	2	20428196
Pubmed	The murine Ia alpha chains, E alpha and A alpha, show a surprising degree of sequence homology.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	6300851
Pubmed	Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis.	ULBP2 MICA	4.09e-05	3	129	2	18791713
Pubmed	Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	9053454
Pubmed	Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.	BCAR1 PRDM1	4.09e-05	3	129	2	28442738
Pubmed	Beta-agonists enhance the lactic dehydrogenase (LDH) expression in serum and ventricular myocytes of mice.	LDHB LDHC	4.09e-05	3	129	2	17853776
Pubmed	Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.	PTPRZ1 ALK	4.09e-05	3	129	2	23777859
Pubmed	Properties of human testis-specific lactate dehydrogenase expressed from Escherichia coli.	LDHB LDHC	4.09e-05	3	129	2	1996957
Pubmed	Developmental regulation of expression of the lactate dehydrogenase (LDH) multigene family during mouse spermatogenesis.	LDHB LDHC	4.09e-05	3	129	2	2401207
Pubmed	Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?	LDHB LDHC	4.09e-05	3	129	2	17178662
Pubmed	HLA class II nucleotide sequences, 1992.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	1362295
Pubmed	Circulating, soluble forms of major histocompatibility complex antigens are not exosome-associated.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	17072917
Pubmed	Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	17404272
Pubmed	The class II molecules of the human and murine major histocompatibility complex.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	6198089
Pubmed	Plasmacytoid dendritic cells induce tolerance predominantly by cargoing antigen to lymph nodes.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	27592607
Pubmed	Expression of TNRC6 (GW182) Proteins Is Not Necessary for Gene Silencing by Fully Complementary RNA Duplexes.	TNRC6C TNRC6A	4.09e-05	3	129	2	31670606
Pubmed	The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	2882518
Pubmed	Revisiting the specificity of the MHC class II transactivator CIITA in vivo.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	16703565
Pubmed	Crystal structure of I-Ak in complex with a dominant epitope of lysozyme.	HLA-DQA1 HLA-DQA2	4.09e-05	3	129	2	9529148
Interaction	GARRE1 interactions	GIGYF1 TNRC6C BCAR1 LDHB TNRC6A ANKRD17 TNKS1BP1 CSPP1	9.71e-06	167	125	8	int:GARRE1
Interaction	CFC1 interactions	CNTNAP3B HLA-F CNTNAP3 LRIG2 CFC1 PLXNA1 HYAL2	1.37e-05	126	125	7	int:CFC1
Interaction	CNOT9 interactions	GIGYF1 TNRC6C ANKHD1 BIRC6 LDHB TNRC6A ANKRD17 TNKS1BP1 CSPP1	1.41e-05	231	125	9	int:CNOT9
Cytoband	7q31.32	TMEM229A TMEM168	5.99e-04	13	129	2	7q31.32
Cytoband	1q22-q23	ITLN2 CD1E	5.99e-04	13	129	2	1q22-q23
Cytoband	Ensembl 112 genes in cytogenetic band chr7q31	CTTNBP2 TMEM229A TMEM168 PTPRZ1	6.79e-04	140	129	4	chr7q31
GeneFamily	C1-set domain containing	HLA-DQA1 HLA-DQA2 HLA-F CD1E MICA	1.90e-06	42	89	5	591
GeneFamily	EF-hand domain containing\|S100 fused type protein family	FLG HRNR	4.95e-04	7	89	2	1350
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-DQA1 HLA-DQA2 HLA-F	1.32e-03	44	89	3	588
Coexpression	NABA_MATRISOME	FLG MASP1 COL12A1 IMPG1 ITLN2 HRNR SNED1 CELA3B CELA3A FGF21 CFC1 FGA LOXL4 CFC1B PLXNA1 CTSZ HYAL2 COL1A1	2.62e-06	1026	128	18	M5889
Coexpression	NABA_MATRISOME	MASP1 COL12A1 IMPG1 ITLN2 HRNR SNED1 CELA3B CELA3A FGF21 CFC1 FGA LOXL4 CFC1B PLXNA1 CTSZ HYAL2 COL1A1	8.56e-06	1008	128	17	MM17056
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000	VGLL3 COL12A1 CPXM2 HLA-DQA1 CNTNAP3 PTGIS PTPRZ1 SYNE2 LOXL4 ADGRD1 COL1A1	1.10e-05	369	124	11	gudmap_kidney_adult_RenalCapsule_k2_1000
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 PLB1 COL12A1 CTTNBP2 PTPRZ1 RXFP2 CNTNAP2	4.16e-07	160	128	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 PLB1 COL12A1 CTTNBP2 PTPRZ1 RXFP2 CNTNAP2	4.16e-07	160	128	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2\|lymph-node_spleen / Manually curated celltypes from each tissue	TRPM4 VGLL3 HLA-DQA1 HLA-DQA2 DNAI1 CD1E CTSZ	7.89e-07	176	128	7	72a3bbab0540ae3e3c94b9573cdb9298a024dbc4
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SOX10 MAL TMEM229A DISC1 LDHB FUT8 ZBTB3	1.23e-06	188	128	7	c2febf9fd4632af1f922067c3a30e5c50f75f480
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MASP1 VGLL3 CPXM2 ARHGAP10 PTGIS CADPS COL1A1	1.32e-06	190	128	7	562ee3b025c29edf07b8b344323edb49d82f1c7e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MASP1 VGLL3 CPXM2 ARHGAP10 PTGIS CADPS COL1A1	1.32e-06	190	128	7	f5fb989afabb49d64d91324570cd8c80a4b9e67d
ToppCell	Mesenchymal_cells-Ng2+_MSCs\|World / Lineage and Cell class	SDK2 COL12A1 PTGIS RGS3 PTPRZ1 LOXL4 COL1A1	1.41e-06	192	128	7	0703b8ec6960ff975ee5a2737054db67cab016b5
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SDK2 COL12A1 CYP26B1 CPXM2 LDHB LOXL4 FUT8	1.68e-06	197	128	7	4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SDK2 COL12A1 CYP26B1 CPXM2 LDHB LOXL4 FUT8	1.68e-06	197	128	7	ece0c17eb68f394b20e588c0b0626d3987a4dbbb
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	VGLL3 HLA-DQA1 HLA-DQA2 HLA-F RGS3 KSR1 COL1A1	1.79e-06	199	128	7	fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B COL12A1 CNTNAP3 PRDM1 PTPRZ1 CNTNAP2 ALK	1.85e-06	200	128	7	4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B COL12A1 CNTNAP3 PRDM1 PTPRZ1 CNTNAP2 ALK	1.85e-06	200	128	7	fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B COL12A1 CNTNAP3 PRDM1 PTPRZ1 CNTNAP2 ALK	1.85e-06	200	128	7	c6eda342ea0cb37d71d89dbb8d11e819e0745172
ToppCell	TCGA-Mesothelium\|World / Sample_Type by Project: Shred V9	PLB1 VGLL3 RAET1G ITLN2 PTGIS ADGRD1	2.11e-06	130	128	6	3ef1733eb57e2a9a3298ce0d65401f19e2084df1
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAL LDHB LDHC PRDM1 USP2 SYNE2	5.61e-06	154	128	6	89c9c9918af32f3952790b41f1471b2c80ffce2f
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRPM4 CTTNBP2 HLA-DQA1 HLA-DQA2 SYT2 CD1E	8.04e-06	164	128	6	3a4ecc632be003d09b765c992804134348d2278b
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TRPM4 CTTNBP2 HLA-DQA1 HLA-DQA2 SYT2 CD1E	8.04e-06	164	128	6	4b10b78d4d76023c3c5bcd427757218fdd5465ca
ToppCell	10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory\|Liver / Manually curated celltypes from each tissue	CNTNAP3B HLA-DQA1 HLA-DQA2 HRNR OSBPL10 FCRL4	1.02e-05	171	128	6	eb47f4a09a630ed14a0898377039ed50ef7cc292
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B TRPM4 CNTNAP3 CDC42EP3 DNAI1 ALK	1.37e-05	180	128	6	8f774dcacc1626e4e6492f1eb927b0ed56fbe686
ToppCell	metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	TRPM4 CTTNBP2 HLA-DQA1 HLA-DQA2 NUTM1 CD1E	1.37e-05	180	128	6	289f8c4b53ffd164fee1f459a9315c0deb5f76d0
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 VGLL3 ARHGEF17 PTGIS FGA COL1A1	1.45e-05	182	128	6	f4b74c2756989812abe4e7055ec8918f69d56025
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CDC42EP3 PRDM1 DNAI1 ALK	1.50e-05	183	128	6	d2074b13b4831ec18c81273d9a1ff673c3f6a16d
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MICAL1 KIF26A CDC42EP3 KCNH3 HSD11B2 FUT8	1.50e-05	183	128	6	ee9c88be88221b7ad4ea9f890b17d6156fb3432e
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MICAL1 KIF26A CDC42EP3 KCNH3 HSD11B2 FUT8	1.50e-05	183	128	6	c52b84034503d931f7b87312d2ff86daff14152d
ToppCell	P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ZMYND15 CYP26B1 CDC42EP3 RGS3 HSD11B2 HYAL2	1.55e-05	184	128	6	8ed22b1af04a711203293e7a8b3df6fb9222fad5
ToppCell	Striatum-Endothelial-ENDOTHELIAL_TIP\|Striatum / BrainAtlas - Mouse McCarroll V32	COL12A1 CYP26B1 CPXM2 LOXL4 COL1A1	1.59e-05	109	128	5	a84a4a3ac19692e5595b9820d49e12ae336f4bbf
ToppCell	Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-\|Striatum / BrainAtlas - Mouse McCarroll V32	COL12A1 CYP26B1 CPXM2 LOXL4 COL1A1	1.59e-05	109	128	5	f7d7b67f7585f2ae0ac905bcf3980264cf9234b8
ToppCell	Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Striatum / BrainAtlas - Mouse McCarroll V32	COL12A1 CYP26B1 CPXM2 LOXL4 COL1A1	1.59e-05	109	128	5	f007fa3dc92d6c8543585e47ccec218263b3266e
ToppCell	Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Striatum / BrainAtlas - Mouse McCarroll V32	COL12A1 CYP26B1 CPXM2 LOXL4 COL1A1	1.59e-05	109	128	5	f4b9fe5335cabe48a5fae7ec51bab0d7bdb17321
ToppCell	Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)\|Striatum / BrainAtlas - Mouse McCarroll V32	COL12A1 CYP26B1 CPXM2 LOXL4 COL1A1	1.59e-05	109	128	5	8460683529759585bd363d10a16ee13af2bd4e28
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL12A1 CPXM2 CDC42EP3 PTGIS CNTNAP2 COL1A1	1.64e-05	186	128	6	4e983de6d2515082f9e555f4f949cec84281c140
ToppCell	facs-Heart-LA-24m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 LDHB LDHC PTGIS ADGRD1 COL1A1	1.64e-05	186	128	6	ed0a91f47e77fe21d4c7678d0f2a7c5f97d63dda
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B COL12A1 CNTNAP3 PRDM1 PTPRZ1 ALK	1.69e-05	187	128	6	d413fb4b1531b297af5012a392b88128510c2de8
ToppCell	facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 LDHC PTGIS CPQ ADGRD1 COL1A1	1.69e-05	187	128	6	f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6
ToppCell	facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 LDHC PTGIS CPQ ADGRD1 COL1A1	1.69e-05	187	128	6	1669df899b1759c338ffce196fe009840123cfcd
ToppCell	Mesenchymal_cells-Ng2+_MSCs\|Mesenchymal_cells / Lineage and Cell class	SDK2 CDC42EP3 PTGIS RGS3 PTPRZ1 LOXL4	1.69e-05	187	128	6	e899b906409f3fad69cb3d3c6432c3fd862ae3c1
ToppCell	Mesenchymal_cells-Osteoblasts\|World / Lineage and Cell class	PLB1 SDK2 PTGIS RGS3 PTPRZ1 COL1A1	1.75e-05	188	128	6	89f7f5a51be7e046a63e2413f86c521ae4b6718f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CDC42EP3 PRDM1 DNAI1 ALK	1.80e-05	189	128	6	99a13b1b669b0cd36e3096632351d9ade25d1173
ToppCell	CTRL-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	HLA-DQA1 SNED1 OSBPL10 FCRL4 FUT8 CTSZ	1.80e-05	189	128	6	14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e
ToppCell	390C-Myeloid-Macrophage-FABP4+_Macrophage_2\|390C / Donor, Lineage, Cell class and subclass (all cells)	ZMYND15 ARRDC4 HLA-DQA1 HLA-DQA2 DDO CTSZ	1.80e-05	189	128	6	3b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 CPXM2 ARHGAP10 CADPS ADGRD1 COL1A1	1.85e-05	190	128	6	2e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 PRDM1 CNTNAP2 OSBPL10 ALK	1.85e-05	190	128	6	d19bc44310c53726e2f5f6a2bd377bbbf1d1983f
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGLL3 ARHGEF17 PTGIS RTN2 CPQ COL1A1	1.85e-05	190	128	6	00fd993675faf53adf985b9316a18c8a33242029
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	VGLL3 CPXM2 PTGIS SNED1 ADGRD1 COL1A1	1.85e-05	190	128	6	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 CPXM2 ARHGAP10 CADPS ADGRD1 COL1A1	1.85e-05	190	128	6	0028f886c789ba238c031eae5d96acaed4af8c25
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 PRDM1 DNAI1 PTPRZ1 ALK	1.85e-05	190	128	6	305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VGLL3 ARHGEF17 PTGIS RTN2 CPQ COL1A1	1.85e-05	190	128	6	8cda09d761c6b504a744959d587c183f94f1beeb
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CDC42EP3 PRDM1 DNAI1 ALK	1.85e-05	190	128	6	0acf1d5da68db449d8c9e70519a236ce825f9d11
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 CDC42EP3 PRDM1 DNAI1 ALK	1.85e-05	190	128	6	e58e4b6fbeb4368f738adac67ec10879c0966f0f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAL APBB1 TNRC6C LDHB SYNE2 TNRC6A	1.91e-05	191	128	6	696921a4f160b6b55698652488ed781e855e5e51
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	KIF26A CNTNAP3 BCAR1 SNED1 TNKS1BP1 HYAL2	1.91e-05	191	128	6	dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA0408 RPH3A ARHGAP31 FCRL4 ALK PLXNA1	1.97e-05	192	128	6	63d1b3efe93e5ff939278ebe40bacb38218ea09b
ToppCell	droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP26B1 CPXM2 PTGIS HSD11B2 ADGRD1 COL1A1	2.03e-05	193	128	6	59b8186d0221fba06a16157e9d148399ed801f38
ToppCell	COVID-19-Myeloid-TRAM1\|Myeloid / Condition, Lineage and Cell class	VGLL3 HLA-DQA1 HLA-DQA2 BCAR1 LDHB CDC42EP3	2.03e-05	193	128	6	6e6a7f4e50c8ae70bc187b9ce77140a7049dd288
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL12A1 CYP26B1 CNTNAP3 PTGIS CNTNAP2 COL1A1	2.03e-05	193	128	6	cd45118ced91b10baed3b1068d4673ec99824b86
ToppCell	droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP26B1 CPXM2 PTGIS HSD11B2 ADGRD1 COL1A1	2.03e-05	193	128	6	dc92680b4bb9fc26430c92e03adb839c8c3b3b98
ToppCell	droplet-Pancreas-Endocrine-21m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP26B1 CPXM2 PTGIS HSD11B2 ADGRD1 COL1A1	2.03e-05	193	128	6	03678162648bd5b1d65a5450b60c8863edbf95c7
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CNTNAP3B CNTNAP3 PRDM1 CADPS CNTNAP2 ALK	2.09e-05	194	128	6	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 COL12A1 ARHGAP10 PTGIS ADGRD1 COL1A1	2.15e-05	195	128	6	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VGLL3 COL12A1 ARHGAP10 PTGIS ADGRD1 COL1A1	2.15e-05	195	128	6	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPXM2 ARHGAP10 PTGIS CADPS ADGRD1 COL1A1	2.21e-05	196	128	6	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPXM2 ARHGAP10 PTGIS CADPS ADGRD1 COL1A1	2.21e-05	196	128	6	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	VGLL3 COL12A1 CYP26B1 HOXB-AS3 PLXNA1 COL1A1	2.34e-05	198	128	6	8b9e8eaeffda40912a0163fdf39b93bc5e64751c
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	VGLL3 COL12A1 CYP26B1 HOXB-AS3 PLXNA1 COL1A1	2.34e-05	198	128	6	eb78b2ae6a787dbc75947e8dd5a03693285bc8be
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	CNTNAP3B CPXM2 LDHB CDC42EP3 HIPK3 SYNE2	2.34e-05	198	128	6	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	facs-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SDK2 COL12A1 CYP26B1 CPXM2 LOXL4 FUT8	2.34e-05	198	128	6	71e847e8c24744d6df4a960348ad2ecf310373b4
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	VGLL3 COL12A1 HOXB-AS3 KLF14 PTGIS COL1A1	2.41e-05	199	128	6	60a653100aff31f7f96796ff2ec634798bfb4b0d
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	HLA-DQA1 HLA-DQA2 HLA-F CDC42EP3 PTGIS SYNE2	2.47e-05	200	128	6	2ae62c428728c1d9d4471d4be24bd6ab074fa22c
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 PRDM1 PTPRZ1 CNTNAP2 ALK	2.47e-05	200	128	6	1276bfa911fddada4235e12e3081baa53164574b
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VGLL3 COL12A1 PTGIS CPQ ADGRD1 COL1A1	2.47e-05	200	128	6	cfea2f9d85646c9b722150551ff2e8fc4f6cc98a
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 PRDM1 PTPRZ1 CNTNAP2 ALK	2.47e-05	200	128	6	5ec469267747dce3601c1d8ad01af89fa5b29acc
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 CDC42EP3 DNAI1 CNTNAP2 ALK	2.47e-05	200	128	6	c65e6336725856c4b5f6aeba1cf86a23ec815d34
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	CTTNBP2 CYP26B1 PTGIS SYNE2 FUT8 HYAL2	2.47e-05	200	128	6	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 PRDM1 PTPRZ1 CNTNAP2 ALK	2.47e-05	200	128	6	e79d93d55b25804f2608185168da472301b6ebca
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	MASP1 COL12A1 PTGIS CADPS ADGRD1 COL1A1	2.47e-05	200	128	6	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 CDC42EP3 DNAI1 CNTNAP2 ALK	2.47e-05	200	128	6	117a25b3b9cdbc2e198381350a8362bee25e82e7
ToppCell	Neuronal-Inhibitory-iB\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 PRDM1 CADPS CNTNAP2 ALK	2.47e-05	200	128	6	45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 CDC42EP3 DNAI1 CNTNAP2 ALK	2.47e-05	200	128	6	d459e51507bf26865e6e7e04411379ec82a3edf8
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CNTNAP3B CNTNAP3 PRDM1 PTPRZ1 CNTNAP2 ALK	2.47e-05	200	128	6	320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0408 VGLL3 SYT2 ADGRD1 COL1A1	6.45e-05	146	128	5	86cddd0e7f954547b7ffdccb0329cd5c4b725ac1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAL TRIM35 RTN2 CELA3B KSR1	6.66e-05	147	128	5	2d9044ddf01b6838a44a4518b442d7e7cb0bf910
ToppCell	Leuk-UTI-Lymphocyte-T_NK-CD8_TCM\|Leuk-UTI / Disease, Lineage and Cell Type	MAL ZNF157 LDHB PRDM1 OSBPL10	7.33e-05	150	128	5	0a65f5e2f4e0b0e822b029e0222b28ba2db89e6d
ToppCell	Thalamus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf\|Thalamus / BrainAtlas - Mouse McCarroll V32	MASP1 MAL GGT6 HSD11B2	7.57e-05	78	128	4	5b45aacaff2a2b98c4ef8e7ac51ad482a69a1d8b
ToppCell	Thalamus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)\|Thalamus / BrainAtlas - Mouse McCarroll V32	MASP1 MAL GGT6 HSD11B2	7.57e-05	78	128	4	afed2f358c8a33889931bc5ad8cb24f92323e6f8
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAL TMEM229A LDHB SYNE2 HSFX1	8.05e-05	153	128	5	7480522a47e367f8facc4f5d599fbaf0b5ad4007
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-liver_dendritic_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MASP1 HLA-DQA1 HLA-DQA2 CD1E FGA	8.82e-05	156	128	5	411c170a7dd65269ae442b8069caf5231bddb116
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MAL TMEM229A LDHB SYNE2 HSFX1	8.82e-05	156	128	5	53ded973358e3e48054130131e959f0d1f4ef60f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGEF17 CELA3B KLF17 ALK ADGRD1	9.09e-05	157	128	5	bfec34182f052cf1c0d847ba53ea335d4d1190de
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZNF157 CNTNAP3 NUTM1 DNAI1 CSPP1	9.09e-05	157	128	5	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLB1 CPXM2 GGT6 KLC4 NFATC3	9.65e-05	159	128	5	1baf0eaf9684668146a63192e77eec6c3c7a37f8
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-Treg\|Multiple_Sclerosis / Disease, Lineage and Cell Type	MAL LDHB PRDM1 SYNE2 RPL4	1.05e-04	162	128	5	975d52e3cc101e7592425128e1099d30847a8a42
ToppCell	Bronchial-10x5prime-Stromal-Schwann\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SOX10 MAL ARHGEF17 PTPRZ1 COL1A1	1.05e-04	162	128	5	afffecc6c504930554aafc12c5bffa53e3c5b016
ToppCell	367C-Fibroblasts-Fibroblast-F\|367C / Donor, Lineage, Cell class and subclass (all cells)	IMPG1 CPXM2 SYT2 PTGIS ADGRD1	1.18e-04	166	128	5	2887f4f0c218cbcbcc82eef27aa4ee714b35cddb
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated\|Liver / Manually curated celltypes from each tissue	ARMCX4 LDHB LENG9 SNED1 ZBTB3	1.18e-04	166	128	5	9afa33b5ad27dc33576be592f9b22d8161366838
ToppCell	367C-Fibroblasts-Fibroblast-F-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IMPG1 CPXM2 SYT2 PTGIS ADGRD1	1.18e-04	166	128	5	1cc291a04f4144abba4aca7badeb7776db05d903
ToppCell	facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTNAP3 ARHGEF17 DNAI1 KSR1 OSBPL10	1.21e-04	167	128	5	961e722442d786ab15d1e490941d2be265a9057a
ToppCell	facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNTNAP3 ARHGEF17 DNAI1 KSR1 OSBPL10	1.21e-04	167	128	5	3760efc35d4e7e9c2da1a20f9795ddea397e2206
ToppCell	3'_v3-blood-Lymphocytic_B-ABC_aged-B_memory\|blood / Manually curated celltypes from each tissue	LDHAL6A HLA-DQA1 HLA-DQA2 CNTNAP2 OSBPL10	1.25e-04	168	128	5	2ce1a30feb2704a9516d1dab161a26cb0555abb5
ToppCell	severe-Myeloid-mDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HLA-DQA1 HLA-DQA2 LDHB CD1E RPL4	1.25e-04	168	128	5	eff37a92d41624924201372cc09f9eb07b60aec1
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL12A1 LDHAL6A ITLN2 MICA PLXNA1	1.28e-04	169	128	5	cd16e8462ee09877be962fbd9a3badcb825820b0
Drug	ox-Q	LDHAL6A LDHB LDHC	7.08e-07	4	129	3	CID000448650
Drug	spirobishexahydropyrimidine	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000100750
Drug	AC1O5TJF	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID006440410
Drug	1,4-diethoxybutane	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000232578
Drug	C4H3NO4	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000448651
Drug	S-lac-NAD	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000194292
Drug	sorbarin	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID009824100
Drug	AC1O5ZB9	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID006443605
Drug	AC1L49DG	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000152931
Drug	N-trifluoroacetyl-glycine	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000136227
Drug	acetylphosphonic acid	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000081311
Drug	NSC-60195	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000020481
Drug	ethyl gossypol	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000374353
Drug	oxyayanin A	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID005281676
Drug	B-HAD	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000131338
Drug	SQ 31,486	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000130015
Drug	BMS-188107	LDHAL6A LDHB LDHC	1.76e-06	5	129	3	CID000192297
Drug	BL-443	LDHAL6A LDHB LDHC	3.51e-06	6	129	3	CID000054436
Drug	dansyl-L-lysine	LDHAL6A LDHB LDHC	3.51e-06	6	129	3	CID000598797
Drug	I 65	LDHAL6A LDHB LDHC	3.51e-06	6	129	3	CID000149068
Drug	D 701	LDHAL6A LDHB LDHC	3.51e-06	6	129	3	CID003051460
Drug	2,3-dihydroxy-1-naphthoic acid	LDHAL6A LDHB LDHC	3.51e-06	6	129	3	CID000028002
Drug	AC1L24G8	LDHAL6A LDHB LDHC	3.51e-06	6	129	3	CID000066023
Drug	oxymethacil	LDHAL6A LDHB LDHC	3.51e-06	6	129	3	CID000096369
Drug	SQ 32,926	LDHAL6A LDHB LDHC	3.51e-06	6	129	3	CID000131363
Drug	AC1O7170	LDHAL6A LDHB LDHC	6.12e-06	7	129	3	CID006540699
Drug	BS35	LDHAL6A LDHB LDHC	6.12e-06	7	129	3	CID000029316
Drug	BS36	LDHAL6A LDHB LDHC	6.12e-06	7	129	3	CID000029308
Drug	pentabromoacetone	LDHAL6A LDHB LDHC	6.12e-06	7	129	3	CID000065579
Drug	methyl-4-hydroxy-3-nitrobenzimidate	LDHAL6A LDHB LDHC	6.12e-06	7	129	3	CID005492576
Drug	gossylic iminolactone	LDHAL6A LDHB LDHC	6.12e-06	7	129	3	CID005479302
Drug	N-acetyl-9-O-lactylneuraminic acid	LDHAL6A LDHB LDHC	6.12e-06	7	129	3	CID000191486
Drug	sodium glycolate	LDHAL6A LDHB LDHC	6.12e-06	7	129	3	CID000517347
Drug	AC1NSM0G	LDHAL6A LDHB LDHC	6.12e-06	7	129	3	CID005365671
Drug	p-(phenoxypropoxy)aniline	LDHAL6A LDHB LDHC	9.75e-06	8	129	3	CID000423258
Drug	BS37	LDHAL6A LDHB LDHC	9.75e-06	8	129	3	CID000027925
Drug	U75412E	LDHAL6A LDHB LDHC	9.75e-06	8	129	3	CID003035460
Drug	AC1Q3O0A	LDHAL6A LDHB LDHC	9.75e-06	8	129	3	CID000060880
Drug	UR-12633	LDHAL6A LDHB LDHC	9.75e-06	8	129	3	CID000128030
Drug	2-methyl-2-pentenoate	LDHAL6A LDHB LDHC	9.75e-06	8	129	3	CID000018458
Drug	AC1L4GHU	LDHAL6A LDHB LDHC	9.75e-06	8	129	3	CID000156607
Drug	N-dodecyl morpholine	LDHAL6A LDHB LDHC	9.75e-06	8	129	3	CID000073764
Drug	S-(2-chloroethyl)-L-cysteine	LDHAL6A LDHB LDHC	9.75e-06	8	129	3	CID000034229
Drug	benzamyl	LDHAL6A LDHB LDHC	1.46e-05	9	129	3	CID000160884
Drug	Bcdfg	LDHAL6A LDHB LDHC	1.46e-05	9	129	3	CID003036106
Drug	N-acetyl-ala-ala-ala-methyl ester	LDHAL6A LDHB LDHC	1.46e-05	9	129	3	CID000100120
Drug	DMTU	LDHAL6A RBP3 BCAR1 LDHB LDHC	1.50e-05	55	129	5	CID002723631
Drug	Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A	MICAL1 CDHR2 DISC1 CDC42EP3 RPH3A HIPK3 CD1E CPQ	1.64e-05	196	129	8	4423_DN
Drug	hydroxyisonobilin	LDHAL6A LDHB LDHC	2.07e-05	10	129	3	CID006438562
Drug	pyridinophane cryptand	LDHAL6A LDHB LDHC	2.07e-05	10	129	3	CID006454246
Drug	sodium oxamate	LDHAL6A LDHB LDHC	2.07e-05	10	129	3	CID000005242
Drug	FK3311	LDHAL6A LDHB LDHC	2.07e-05	10	129	3	CID000164009
Drug	2-keto-4-mercaptobutyric acid	LDHAL6A LDHB LDHC	2.07e-05	10	129	3	CID000151198
Drug	bis-NAD	LDHAL6A LDHB LDHC	2.07e-05	10	129	3	CID003081557
Drug	mivazerol	LDHAL6A LDHB LDHC	2.07e-05	10	129	3	CID000060783
Drug	phosphoenolthiopyruvate	LDHAL6A LDHB LDHC	2.07e-05	10	129	3	CID000194910
Drug	hexandiol	LDHAL6A LDHB LDHC	2.84e-05	11	129	3	CID000147023
Drug	5-ethylphenazin-5-ium	LDHAL6A LDHB LDHC	2.84e-05	11	129	3	CID000082689
Drug	hydrazinium nitrate	LDHAL6A LDHB LDHC	2.84e-05	11	129	3	CID000166817
Drug	polyvinylpyridine-N-oxide	LDHAL6A LDHB LDHC	2.84e-05	11	129	3	CID000024772
Drug	LG61	LDHAL6A LDHB LDHC	3.77e-05	12	129	3	CID000520177
Drug	U74500A	LDHAL6A LDHB LDHC	3.77e-05	12	129	3	CID000107964
Drug	decoxymethanol	LDHAL6A LDHB LDHC FGA RPL4	4.87e-05	70	129	5	CID004629337
Drug	diphenaldehyde	LDHAL6A LDHB LDHC	4.88e-05	13	129	3	CID000014585
Drug	3-mercaptolactic acid	LDHAL6A LDHB LDHC	4.88e-05	13	129	3	CID000160645
Drug	2-oxohexanoate	LDHAL6A LDHB LDHC	4.88e-05	13	129	3	CID000159664
Drug	T 514	LDHAL6A LDHB LDHC	4.88e-05	13	129	3	CID000114820
Drug	Mctp	LDHAL6A LDHB LDHC LOXL4	5.62e-05	37	129	4	CID000129268
Drug	beryllium nitrate	LDHAL6A LDHB LDHC	6.18e-05	14	129	3	CID000026126
Drug	scymnol	LDHAL6A LDHB LDHC	6.18e-05	14	129	3	CID000165531
Drug	AC1L3P2T	LDHAL6A LDHB LDHC	6.18e-05	14	129	3	CID000119585
Drug	ethion	LDHAL6A LDHB LDHC	7.69e-05	15	129	3	CID000003286
Drug	Ac-YVAD-Amc	LDHAL6A LDHB LDHC	7.69e-05	15	129	3	CID000004337
Drug	2-bromohydroquinone	LDHAL6A LDHB LDHC	7.69e-05	15	129	3	CID000068502
Drug	potassium citrate	LDHAL6A LDHB LDHC	9.43e-05	16	129	3	CID000013344
Drug	1-methoxy-5-methylphenazine	LDHAL6A LDHB LDHC	9.43e-05	16	129	3	CID000127832
Drug	tripotassium citrate monohydrate	LDHAL6A LDHB LDHC	9.43e-05	16	129	3	CID002735208
Drug	Calpain Inhibitor Vi	LDHAL6A LDHB LDHC	1.14e-04	17	129	3	CID009885817
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A	SYT2 XRCC4 RTN2 CD1E HSD11B2 CTSZ COL1A1	1.26e-04	195	129	7	2767_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	SOX10 SYT2 USP2 KSR1 CNTNAP2 CTSZ COL1A1	1.34e-04	197	129	7	5207_UP
Drug	4-methoxy-1-naphthaldehyde	LDHAL6A LDHB LDHC	1.36e-04	18	129	3	CID000085217
Drug	acromelic acid A	LDHAL6A LDHB LDHC	1.36e-04	18	129	3	CID000108086
Drug	BW540C	LDHAL6A LDHB LDHC	1.36e-04	18	129	3	CID000134372
Drug	N-(3,5-dichlorophenyl)-2-hydroxysuccinimide	LDHAL6A LDHB LDHC	1.36e-04	18	129	3	CID000114902
Drug	mianserin	SOX10 LDHAL6A LDHB LDHC LOXL4	1.38e-04	87	129	5	CID000004184
Drug	Gelsemine [509-15-9]; Up 200; 12.4uM; MCF7; HT_HG-U133A	SOX10 FLG SYT2 SNED1 KSR1 CNTNAP2 FGA	1.43e-04	199	129	7	4177_UP
Drug	AC1Q4V1U	LDHAL6A LDHB LDHC	1.61e-04	19	129	3	CID000090059
Drug	bimakalim	LDHAL6A LDHB LDHC	1.61e-04	19	129	3	CID000060674
Drug	A816662	LDHAL6A LDHB LDHC	1.61e-04	19	129	3	CID003634887
Drug	AC1L3O3D	LDHAL6A LDHB LDHC	1.89e-04	20	129	3	CID000092422
Drug	oxyphenbutazone	LDHAL6A LDHB LDHC	1.89e-04	20	129	3	CID000004641
Drug	OOS-TMP	LDHAL6A LDHB LDHC	1.89e-04	20	129	3	CID000009039
Drug	11-ketotestosterone	ITLN2 HSD11B2	1.90e-04	4	129	2	ctd:C003600
Drug	AC1Q4I5I	CELA3B CELA3A	1.90e-04	4	129	2	CID000194288
Drug	phenylsuccinate	LDHAL6A LDHB LDHC	2.19e-04	21	129	3	CID000095459
Drug	HBGG	HLA-DQA1 HLA-DQA2 FGA	2.53e-04	22	129	3	CID000125044
Drug	2 MAC	LDHAL6A LDHB LDHC	2.53e-04	22	129	3	CID000005624
Drug	HMR 1098	LDHAL6A LDHB LDHC	2.53e-04	22	129	3	CID003037766
Drug	2-ethylhexanol	LDHAL6A LDHB LDHC	2.53e-04	22	129	3	CID000007720
Drug	alpha-ketovalerate	LDHAL6A LDHB LDHC	2.90e-04	23	129	3	CID000074563
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3 CNTNAP2	3.99e-06	8	124	3	DOID:0060308 (implicated_via_orthology)
Disease	level of UL16-binding protein 6 in blood serum	ULBP2 RAET1L	1.75e-05	2	124	2	OBA_2043185
Disease	glomerulonephritis	HLA-DQA1 OSBPL10	5.24e-05	3	124	2	MONDO_0002462
Disease	double outlet right ventricle (implicated_via_orthology)	CFC1 CFC1B	5.24e-05	3	124	2	DOID:6406 (implicated_via_orthology)
Disease	collagenous colitis	HLA-DQA1 MICA	5.24e-05	3	124	2	EFO_1001293
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	HLA-DQA1 ZNF106 TOMM40L SYNE2 MICA	7.61e-05	103	124	5	EFO_0008595, EFO_0020944
Disease	disease of metabolism (implicated_via_orthology)	LDHAL6A LDHB LDHC	9.12e-05	21	124	3	DOID:0014667 (implicated_via_orthology)
Disease	dextro-looped transposition of the great arteries (implicated_via_orthology)	CFC1 CFC1B	1.05e-04	4	124	2	DOID:0060770 (implicated_via_orthology)
Disease	right atrial isomerism (implicated_via_orthology)	CFC1 CFC1B	1.05e-04	4	124	2	DOID:0060856 (implicated_via_orthology)
Disease	chronic fatigue syndrome (is_implicated_in)	HLA-DQA1 DISC1	1.74e-04	5	124	2	DOID:8544 (is_implicated_in)
Disease	thrombophilia (is_implicated_in)	HLA-DQA1 FGA	2.60e-04	6	124	2	DOID:2452 (is_implicated_in)
Disease	Schizophrenia	SOX10 DISC1 SDCCAG8 SPTBN2 DDO XRCC4 CDC42EP3 ZIC2 PTPRZ1 CNTNAP2 FUT8 ALK	3.55e-04	883	124	12	C0036341
Disease	androsterone sulfate measurement	CPXM2 BIRC6 ALK	3.60e-04	33	124	3	EFO_0021117
Disease	lymphedema, filarial elephantiasis	HLA-DQA1 HLA-F	3.63e-04	7	124	2	EFO_0007272, MONDO_0019297
Disease	DNA repair protein XRCC4 measurement	XRCC4 CFHR4	4.82e-04	8	124	2	EFO_0801532
Disease	visceral heterotaxy (implicated_via_orthology)	DNAI1 CFC1 CFC1B	5.07e-04	37	124	3	DOID:0050545 (implicated_via_orthology)
Disease	susceptibility to plantar warts measurement	HLA-DQA1 HLA-DQA2 TTF1 CNTNAP2	5.74e-04	90	124	4	EFO_0008406
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	ZMYND15 HLA-DQA1 KLF14 FGF21 SYNE2	6.97e-04	166	124	5	EFO_0004530, EFO_0004611
Disease	primary biliary cholangitis (is_implicated_in)	HLA-DQA1 UTP4	7.71e-04	10	124	2	DOID:12236 (is_implicated_in)
Disease	cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3	HLA-DQA1 MICA	7.71e-04	10	124	2	EFO_0001061, EFO_1000166
Disease	response to antineoplastic agent	DISC1 RPH3A MICA COL1A1	8.22e-04	99	124	4	GO_0097327
Disease	Diabetes, Autoimmune	HLA-DQA1 FGF21 HSD11B2	8.46e-04	44	124	3	C0205734
Disease	Brittle diabetes	HLA-DQA1 FGF21 HSD11B2	8.46e-04	44	124	3	C0342302
Disease	Diabetes Mellitus, Sudden-Onset	HLA-DQA1 FGF21 HSD11B2	8.46e-04	44	124	3	C4554117
Disease	Diabetes Mellitus, Ketosis-Prone	HLA-DQA1 FGF21 HSD11B2	8.46e-04	44	124	3	C3837958
Disease	Diabetes Mellitus, Insulin-Dependent	HLA-DQA1 FGF21 HSD11B2	9.04e-04	45	124	3	C0011854
Disease	uveitis (implicated_via_orthology)	HLA-DQA1 HLA-DQA2	9.40e-04	11	124	2	DOID:13141 (implicated_via_orthology)
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	ZMYND15 HLA-DQA1 KLF14 TOMM40L FGF21 CNTNAP2	1.09e-03	274	124	6	EFO_0004530, EFO_0004612
Disease	visceral heterotaxy (is_implicated_in)	CFC1 CFC1B	1.12e-03	12	124	2	DOID:0050545 (is_implicated_in)
Disease	temporal arteritis	HLA-DQA1 MICA	1.12e-03	12	124	2	EFO_1001209
Disease	sphingomyelin measurement	ZMYND15 HLA-DQA1 TNRC6C RPH3A KCNH3 SYNE2	1.17e-03	278	124	6	EFO_0010118
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HLA-DQA1 KLF14 ZNF106 TOMM40L SYNE2 MICA	1.48e-03	291	124	6	EFO_0008317, EFO_0020946
Disease	keratinocyte carcinoma	HLA-DQA1 ULBP2 MICA RAET1L	1.58e-03	118	124	4	EFO_0010176
Disease	triglycerides in very large HDL measurement	HLA-DQA1 TOMM40L FGF21	1.62e-03	55	124	3	EFO_0022324
Disease	hypertension	HOXB-AS3 KLF14 BCAR1 XRCC4 ARHGAP31 RXFP2	1.93e-03	307	124	6	EFO_0000537
Disease	Dermatitis	FLG HLA-DQA1	2.02e-03	16	124	2	C0011603
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	HLA-DQA1 KLF14 ZNF106 SYNE2	2.06e-03	127	124	4	EFO_0008595, EFO_0020947
Disease	Sarcomatoid Renal Cell Carcinoma	LDHB CPQ SYNE2 ALK	2.12e-03	128	124	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	LDHB CPQ SYNE2 ALK	2.12e-03	128	124	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	LDHB CPQ SYNE2 ALK	2.12e-03	128	124	4	C1266044
Disease	Papillary Renal Cell Carcinoma	LDHB CPQ SYNE2 ALK	2.12e-03	128	124	4	C1306837
Disease	Renal Cell Carcinoma	LDHB CPQ SYNE2 ALK	2.12e-03	128	124	4	C0007134
Disease	Post-Traumatic Osteoporosis	FGA WDR1 COL1A1	2.18e-03	61	124	3	C0751406
Disease	Osteoporosis, Senile	FGA WDR1 COL1A1	2.18e-03	61	124	3	C0029459
Disease	Osteoporosis, Age-Related	FGA WDR1 COL1A1	2.18e-03	61	124	3	C0001787
Disease	major depressive disorder (is_implicated_in)	DISC1 CNTNAP2	2.29e-03	17	124	2	DOID:1470 (is_implicated_in)
Disease	Graves disease, thyrotoxic periodic paralysis	HLA-DQA1 MICA	2.29e-03	17	124	2	EFO_0004237, MONDO_0019201
Disease	Osteoporosis	FGA WDR1 COL1A1	2.39e-03	63	124	3	C0029456
Disease	Oral Submucous Fibrosis	MICA COL1A1	2.56e-03	18	124	2	C0029172
Disease	keratoconus	COL12A1 ZNF106 COL1A1	2.73e-03	66	124	3	MONDO_0015486
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	HLA-DQA1 ZNF106 TOMM40L	2.85e-03	67	124	3	EFO_0008595, EFO_0020946
Disease	puberty, height growth measurement	VGLL3 MICA	2.86e-03	19	124	2	EFO_0001382, EFO_0005201
Disease	sporadic amyotrophic lateral sclerosis	MASP1 LDHC PLXNA1 ADGRD1	2.93e-03	140	124	4	EFO_0001357
Disease	polymyositis	SDK2 HLA-DQA1	3.17e-03	20	124	2	EFO_0003063
Disease	opioid dependence	SPTBN2 BCAR1 CDC42EP3 CPQ COL1A1	3.33e-03	237	124	5	EFO_0005611
Disease	allergic disease, age at onset	FLG PLB1 HLA-DQA1	3.36e-03	71	124	3	EFO_0004847, MONDO_0005271
Disease	Autoimmune Hepatitis	HLA-DQA1 MICA	3.49e-03	21	124	2	EFO_0005676
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	LDHB CPQ SYNE2 ALK	3.58e-03	148	124	4	C0279702
Disease	photoreceptor cell layer thickness measurement	IMPG1 RBP3 CFHR4 PRDM1	3.58e-03	148	124	4	EFO_0803370
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	HLA-DQA1 ZNF106 SYNE2 MICA	3.75e-03	150	124	4	EFO_0004611, EFO_0020947
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HLA-DQA1 ZNF106 TOMM40L FGF21	4.03e-03	153	124	4	EFO_0004611, EFO_0020946
Disease	cotinine measurement	DISC1 CNTNAP2	4.18e-03	23	124	2	EFO_0007813
Disease	female reproductive system disease	HLA-DQA1 MICA	4.18e-03	23	124	2	EFO_0009549
Disease	level of Sphingomyelin (d40:2) in blood serum	SYNE2 ANKRD17	4.18e-03	23	124	2	OBA_2045181

Protein segments in the cluster

Peptide	Gene	Start	Entry
ESHQEESWLSVGPGG	TTF1	191	Q15361
EGEETHLWSRSGTQG	MAMDC4	746	Q6UXC1
NETHTSWGGSLPDAQ	CNTNAP3	706	Q9BZ76
LVSGHLDSWDVGQGA	CPQ	286	Q9Y646
GTGSTASGWDVEQAL	BIRC6	4296	Q9NR09
HVVSVAGWGISDGTE	CTSZ	241	Q9UBR2
HLLDLAGSAGATGSW	BCAR1	476	P56945
SSGEGVWSNHGCALT	ADGRD1	516	Q6QNK2
SVAEGTGDTTFSWHR	FCRL4	311	Q96PJ5
EESQLTWTGFAHGEG	APBB1	296	O00213
LNWTSSHFGEVTGSA	CFC1B	51	P0CG36
SGTEVGEGTDEWAQS	DNAI1	31	Q9UI46
SGHWGSSGSQASDSE	FLG	1061	P20930
VSTHEQSESSHGWTG	FLG	3066	P20930
RHWGSSGSQASDSEG	FLG	3331	P20930
IGSNLSTSVGHSGIW	ANKRD17	2446	O75179
STSVGHSGIWSFEGI	ANKRD17	2451	O75179
TTSTGLWGLVNNAGH	HSD11B2	156	P80365
ENGTVHQGDTSWGSS	CDC42EP3	161	Q9UKI2
HQGDTSWGSSGSASQ	CDC42EP3	166	Q9UKI2
GSSGSGDAHSWDTLL	DISC1	316	Q9NRI5
LNWTSSHFGEVTGSA	CFC1	51	P0CG37
WLSNGHSVTEGVSET	HLA-DQA1	146	P01909
LGHVDQSSGGAWAGT	ARMCX4	1366	Q5H9R4
GNHIASGSTDTWNGK	ARRDC4	256	Q8NCT1
TVNGASWHTVAGSLN	CPXM2	581	Q8N436
AAGGWHSVCVSETGD	RCCD1	216	A6NED2
LASSWDVAGGALTHS	PAAT	16	Q9H8K7
TLHCSDGEGAASTWG	RGS3	961	P49796
SGALALTDTWAGSHS	HLA-F	11	P30511
GCHGSGTVQWTQEEG	KCNH3	1066	Q9ULD8
SWDGSVQSGFLTEVH	MICA	36	Q29983
DEGLTSGHSDWSVGS	ARHGEF17	776	Q96PE2
SGHSDWSVGSEESKG	ARHGEF17	781	Q96PE2
SVAVEWSGDGSGTLQ	KLC4	536	Q9NSK0
HLLADGGSFGDWAST	ARHGAP10	661	A1A4S6
PTWGTQGDFSTTHAL	CADPS	441	Q9ULU8
TWLSNGHSVTEGVSE	HLA-DQA2	146	P01906
AGGASEAWAGSHLTS	HYAL2	446	Q12891
GWGVSDCSHSEDVGV	LOXL4	116	Q96JB6
WDVHTSASSQSGGEA	GIGYF1	646	O75420
GVAWSGSESGRDAAT	HOXB-AS3	36	C0HLZ6
TVDGAEHGLPDTSWS	IMPG1	421	Q17R60
ETGHWLLQGSGFQSS	CYP26B1	61	Q9NR63
LGDSLSHKGNEFWGT	DYNC2I1	846	Q8WVS4
GTWIGIEGSHLNAGS	PLXNA1	976	Q9UIW2
TGLGGEHKEDSSWSS	KSR1	171	Q8IVT5
TEGAHGAEGAEWTLA	LENG9	186	Q96B70
HEETSGVGERGWGAS	OR2W5P	301	A6NFC9
HIGDDGSNSVATEPW	CSPP1	1201	Q1MSJ5
TGFEHSGLWVSVLAG	FGF21	6	Q9NSA1
GQSSGFGHHESSSWQ	HRNR	1396	Q86YZ3
GQSSGFGHHESSSWQ	HRNR	1866	Q86YZ3
GQSSGFGHHESSSWQ	HRNR	2336	Q86YZ3
HTGSISQSNDVSGIW	KIAA0408	481	Q6ZU52
GEHGDSSVPLWSGVN	LDHC	191	P07864
LEGAAWAGSSHGSSI	KIF26A	1096	Q9ULI4
SSWGSADSDSGHDSG	KIF26A	1581	Q9ULI4
PGVHVSDLSSSWADG	MICAL1	526	Q8TDZ2
PTHALSGDGEWSGAS	PTPRZ1	986	P23471
AASSWAIGGAASVVH	OR2S2	146	Q9NQN1
ELAGHQTSAESWGTG	RPL4	56	P36578
TSESVAGSHRLGDWG	HIPK3	701	Q9H422
SSHERGGEATWSGSE	GORASP1	351	Q9BQQ3
TAGVDGHSWALSAID	NUP155	451	O75694
EWLVGTHLATGESDG	NUTM1	376	Q86Y26
SAEAGDAGVHLVSGW	DDO	81	Q99489
SDAGSSWAGALEGQA	PRICKLE4	206	Q2TBC4
AHSEGSGWLGDLQTH	CD1E	51	P15812
DSIHATDPDTGAWGQ	CDHR2	501	Q9BYE9
VTSEGFRGTWDHGAS	COL12A1	1666	Q99715
TDGWTPVHAAVDTGN	CTTNBP2	841	Q8WZ74
EDGGWQVHGVTSFVS	CELA3A	226	P09093
WGLFHDSSSGNSTAL	GGT6	151	Q6P531
EDGGWQVHGVTSFVS	CELA3B	226	P08861
NTTDSIVCGEDGWSH	CFHR4	186	Q92496
GAHGGETSWVTLDAA	MAL	76	P21145
GHWTSESSVSGSTGQ	FGA	371	P02671
GGSLLGSSWIVTAAH	MASP1	476	P48740
SGGGGWTLVASVHEN	ITLN2	86	Q8WWU7
ASVWADLRGSSGEGS	KLF14	86	Q8TD94
SSGSSGVHTSWNQGL	KLF17	41	Q5JT82
LGEHGDSSVAVWSGV	LDHB	191	P07195
DISSGSGLNDGQWHE	CNTNAP2	446	Q9UHC6
WNITGTVLASSGDDG	SEH1L	286	Q96EE3
NGSLHISQTWSGDIG	SDK2	551	Q58EX2
DFGSGTGSVTWAAHS	METTL17	191	Q9H7H0
NETHTSWGGSLPDAQ	CNTNAP3B	706	Q96NU0
GGSWLIGVFNSTVHT	OR2AJ1	146	Q8NGZ0
GEWSEGSQAHVTPVA	HSFX1	296	Q9UBD0
CTDRSGISTGHWSGE	FUT8	266	Q9BYC5
WHGGAIVSALSQTGS	DAP3	301	P51398
HLGWVARGTGSGEDS	RTN2	146	O75298
VGSNATGTELRHWSD	SYT2	376	Q8N9I0
GNWLAASGTSAGVHV	UTP4	496	Q969X6
FSQGSHAWEVALGGL	TRIM35	351	Q9UPQ4
VSTAAAAKSGHAWSG	TNRC6C	546	Q9HCJ0
GGDWADSSSVLGHLG	TNRC6C	596	Q9HCJ0
RDSESWDHSGGAGDS	RPH3A	246	Q9Y2J0
PLEWDHTGDVGGSSS	SYNE2	6416	Q8WXH0
GQGDGTTSGHTSLWS	TMEM229A	266	B2RXF0
AVLLGDATEAGSGWH	PTGIS	146	Q16647
HNSWITTGEDSGVGE	SDCCAG8	186	Q86SQ7
GDTSGWATIFGTVHG	RXFP2	81	Q8WXD0
IVNDHPWDSGADGGT	PRDM1	61	O75626
FLWDSGSSVGEITGH	WDR1	131	O75083
QDSWTDSGAKGGSHR	METTL22	56	Q9BUU2
SWSIGGDGNLETHTT	PLB1	1126	Q6P1J6
GASENILGWHGSKSH	OSBPL10	311	Q9BXB5
AGGSTVQDEEWGGAH	SLC39A2	131	Q9NP94
IVWTTGTHASSGGNA	SNED1	191	Q8TER0
TVRHGASFTEQWTDG	TLK2	301	Q86UE8
WAGKSLQEGATGGHS	ALK	891	Q9UM73
GHSGIWSFGVNAVSE	ANKHD1	2396	Q8IWZ3
TVDGCTSHTGAWGKT	COL1A1	1411	P02452
WILEEESSGHGYSGS	ZNF157	86	P51786
SDGSSWEGVGVTPHV	RBP3	1201	P10745
DLVGGQTASDTTWDG	SPTBN2	2111	O15020
AEGSGHSIALWAVSD	TECPR1	946	Q7Z6L1
GHSQARESGVGQTDW	TNKS1BP1	1246	Q9C0C2
GFVITLTDGHSAWTG	XRCC4	31	Q13426
GSALAVASGHSAWIS	SOX10	321	P56693
AEGHGSGSWQLSFDG	RAET1G	131	Q6H3X3
TEDTWLNASVHGGSG	NFATC3	306	Q12968
AEGHSSGSWQFSIDG	RAET1L	131	Q5VY80
SLEEFSFHGSESGGW	ARHGAP31	521	Q2M1Z3
THGTGEWALAGGDTL	TMEM168	506	Q9H0V1
WVATLNVGSGGAHAS	TOMM40L	206	Q969M1
AEGHSSGSWQFSFDG	ULBP2	131	Q9BZM5
TVTSATSAWAGAFHG	VGLL3	286	A8MV65
TSAWAGAFHGTVDIV	VGLL3	291	A8MV65
GTGEWHTFNDSSVTP	USP2	566	O75604
DLLVDGAQGTASWGS	ZMYND15	221	Q9H091
LSNSGAVDWNHNGTG	ZNF106	186	Q9H2Y7
VSGGSTHGTWGSLQE	TNRC6A	411	Q8NDV7
AQSTGAWIVTGGLHT	TRPM4	146	Q8TD43
TAGGHSGLSSNFNEW	ZIC2	516	O95409
SLASAETSGHWGKGE	ZBTB3	206	Q9H5J0
GEHGDSSVPVWSGVN	LDHAL6A	191	Q6ZMR3
SSQSSIGHEDDGWTT	LRIG2	791	O94898